Newsroom

Healthcare Pharmaceutical Biotech

Stay informed with the latest in Healthcare, Pharmaceutical and Biotech press releases through our newsroom. Explore breaking updates, industry trends, and insights shaping these vital sectors—all in one place. Whether it’s innovation, regulatory changes, or breakthroughs, our newsroom keeps you connected to the stories that matter most.

All News

Duly Health and Care's Surgical Centers in Lombard, Westmont Named 2025 Best Ambulatory Surgery Centers by U.S. News and World Report
Healthcare & PharmaceuticalCompany Update

Duly Health and Care's Surgical Centers in Lombard, Westmont Named 2025 Best Ambulatory Surgery Centers by U.S. News and World Report

April 15, 2025 7:00 AM

Duly Health and Care is proud to announce that two of its ambulatory surgery centers, Duly Surgery Center Lombard and Duly Surgery Center Westmont, have been named to U.S. News and World Report's 2025 list of the Best Ambulatory Surgery Centers. Duly Surgical Center Lombard was recognized for Colonoscopy & Endoscopy as well as Orthopedics & Spine, while Duly Surgery Center Westmont earned top marks in Orthopedics & Spine."This honor validates...

Read more
Spago Nanomedical Publishes The Annual Report for 2024
Healthcare & PharmaceuticalEarnings

Spago Nanomedical Publishes The Annual Report for 2024

April 15, 2025 5:30 AM

Spago Nanomedical (STO:SPAGO.ST)(FRA:7UX.F)Spago Nanomedical's annual report for 2024 is from today available at the company's website, https://spagonanomedical.se/investor-relations/#financial-reportsFor further information, please contact Mats Hansen, CEO Spago Nanomedical AB, +46 46 811 88, [email protected] Nanomedical AB is a Swedish company in clinical development phase. The company´s development projects are based on a...

Read more
The DEA Is Defying Supreme Court Axon in MMJ's Cannabis Case - Is DEA a rogue agency?
Healthcare & PharmaceuticalCompany Update

The DEA Is Defying Supreme Court Axon in MMJ's Cannabis Case - Is DEA a rogue agency?

April 15, 2025 5:00 AM

The Supreme Court has spoken. In its landmark Axon Enterprise, Inc. v. FTC decision, the Court affirmed that Americans have the right to challenge unconstitutional agency structures in federal court before enduring prolonged and potentially unlawful administrative proceedings. This ruling was meant to be a shield - protecting individuals and companies from bureaucratic abuse. But the Drug Enforcement Administration (DEA) has decided it doesn't...

Read more
PEAK Scientific and Bioz Extend Partnership, Delivering Data-Driven Validation to Scientists
Healthcare & PharmaceuticalPartnerships

PEAK Scientific and Bioz Extend Partnership, Delivering Data-Driven Validation to Scientists

April 15, 2025 4:00 AM

Bioz, Inc., a pioneer in AI-driven publication management, is pleased to announce the renewal of its partnership with PEAK Scientific, global expert in laboratory gas generation. By continuing to integrate Bioz Badges across its product webpages, PEAK Scientific reinforces its commitment to providing researchers with trusted, peer-reviewed validation for their gas generators.Bioz Prime Badges, the advanced digital marketing widgets that PEAK...

Read more
Electronic Caregiver Launches Addison Care Virtual Assistant for Home Care Industry, Declaring AI-Driven Digital Care as the Future of Aging Support
Healthcare & PharmaceuticalProduct Announcements

Electronic Caregiver Launches Addison Care Virtual Assistant for Home Care Industry, Declaring AI-Driven Digital Care as the Future of Aging Support

April 14, 2025 5:30 PM

Electronic Caregiver, Inc., provider of the groundbreaking Addison Care platform, today announced the launch of a new AI-powered Virtual Care Assistant for Private Duty Home Care, designed to help home care agencies expand revenue, increase market share, and stay ahead in the rapidly evolving health and aging market.As traditional home care demand surges and workforce shortages deepen, digital transformation is no longer optional - it's...

Read more
Bausch Health Announces Adoption of Shareholder Rights Plan
Healthcare & PharmaceuticalCompany Update

Bausch Health Announces Adoption of Shareholder Rights Plan

April 14, 2025 4:30 PM

Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) (the "Company" or "Bausch Health") announces today that its board of directors (the "Board") has approved the adoption of a shareholder rights plan (the "SRP") pursuant to a shareholder rights plan agreement entered into with TSX Trust Company, as rights agent, dated April 14, 2025 (the "Effective Date").The SRP has been adopted to help ensure that all shareholders of the Company are treated...

Read more
Dr. Malini Saba Shares Her Insights on Entrepreneurship and Philanthropy in Revealing New Interview
Healthcare & PharmaceuticalCompany Update

Dr. Malini Saba Shares Her Insights on Entrepreneurship and Philanthropy in Revealing New Interview

April 14, 2025 3:00 PM

In a candid new interview, Dr. Malini Saba, the renowned businesswoman, philanthropist, and advocate for women and children's rights, opens up about her personal experiences and the professional philosophies that have shaped her successful career. The in-depth discussion provides a rare glimpse into the strategic mindset and humanitarian vision of one of the most influential figures in international business and philanthropy today.Dr. Saba...

Read more
Ekol Hospitals Pioneers Robotic Urology Surgery, Offers Hope to UK Patients Amid NHS Delays
Healthcare & PharmaceuticalCompany Update

Ekol Hospitals Pioneers Robotic Urology Surgery, Offers Hope to UK Patients Amid NHS Delays

April 14, 2025 12:45 PM

Robotic surgery in urology is a fast-growing field worldwide - the global urology robotics market is projected to expand from $6.72 billion in 2024 to about $28.6 billion by 2033, reflecting an annual growth rate of roughly 17.7%. Yet in the UK, patients often struggle to access these advanced procedures in a timely manner. NHS waiting times for urological surgeries, including prostate cancer treatments, have reached record highs - averaging up...

Read more
CLS Health Introduces Full-Spectrum Eye Care at Clear Lake Campus
Healthcare & PharmaceuticalCompany Update

CLS Health Introduces Full-Spectrum Eye Care at Clear Lake Campus

April 14, 2025 9:30 AM

CLS Health has expanded its specialty care offerings with the launch of full-spectrum ophthalmology and optometry services at its Clear Lake Campus. As the region's leading physician-owned medical group continues to grow, this development marks a significant milestone in delivering coordinated, high-quality vision care to patients in the greater Houston area."The introduction of comprehensive eye care reflects CLS Health's ongoing commitment to...

Read more
Invitation to Presentation of Senzime's First Quarter 2025 Report
Healthcare & PharmaceuticalCompany Update

Invitation to Presentation of Senzime's First Quarter 2025 Report

April 14, 2025 9:15 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) invites investors, analysts, and media to a webcast presentation of the first quarter report for 2025 on April 22, 14:00 CEST. The report will be published during the morning of the same day.The presentation will be held by Philip Siberg, CEO of Senzime, and after the presentation, there will be a Q&A session moderated by Klas Palin, analyst at Carnegie Investment Bank. The presentation will be held in...

Read more
Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
Healthcare & PharmaceuticalConferences

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17

April 14, 2025 8:30 AM

Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), a developer of a multi-faceted patent-pending drug delivery technology, today announced that Kraig Higginson, CEO of Aspire, will present at the Emerging Growth Conference.Virtual Presentation DetailsDate: April 17, 2025Time of Presentation: 12:35 p.m. EDTFormat: Corporate presentation with Q&AParticipants can register for and view the webcast, along with accompanying...

Read more
CERTIFY Health Appoints Cameron Blaylock as Vice President of Healthcare Payments
Healthcare & PharmaceuticalManagement Changes

CERTIFY Health Appoints Cameron Blaylock as Vice President of Healthcare Payments

April 14, 2025 8:00 AM

CERTIFY Health, a leader in digital healthcare solutions and patient engagement technologies, proudly announces the appointment of Cameron Blaylock as its new Vice President of Healthcare Payments.With more than a decade of experience across financial services, payments innovation, and strategic sales, Cameron will lead CERTIFY Health's expanding healthcare payments division-focused on optimizing revenue cycles, simplifying patient financial...

Read more
Rapid Expansion of Healthcare Outsourcing Market to Reach $662 Billion by 2028, Driven by Workforce Shortages and Digital Transformation, Black Book Report
Healthcare & PharmaceuticalAwards

Rapid Expansion of Healthcare Outsourcing Market to Reach $662 Billion by 2028, Driven by Workforce Shortages and Digital Transformation, Black Book Report

April 14, 2025 8:00 AM

The U.S. healthcare outsourcing market is experiencing explosive growth, with total market value expected to surge from $366.6 billion in 2025 to $662 billion by 2028, according to the newly released Black Book Insights research report, The Rapid Expansion of Healthcare Outsourcing: Strategic Outlook 2025-2028. The full report, including the complete dataset, detailed segment analysis, and additional forecasts, is now available for download at...

Read more
Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan
Healthcare & PharmaceuticalCompany Update

Ainos Secures TFDA Approval and IRB Clearance to Advance VELDONA Clinical Trials for HIV Oral Warts and Sjögren's Syndrome in Taiwan

April 14, 2025 8:00 AM

Ainos, Inc. (Nasdaq:AIMD, AIMDW) ("Ainos" or the "Company"), pioneer of low-dose oral interferon therapeutics, today announced significant progress in advancing its oral interferon drug platform, VELDONA® in the rare disease space. The Taiwan Food and Drug Administration (TFDA) has approved the Company's clinical trial for human immunodeficiency virus (HIV)-related oral warts, while Institutional Review Board (IRB) clearance has been granted for...

Read more
SF Bay Area to Celebrate ‘420’ Cannabis Culture and Psychedelic Spirituality during Easter Weekend Fest
Healthcare & PharmaceuticalConferences

SF Bay Area to Celebrate ‘420’ Cannabis Culture and Psychedelic Spirituality during Easter Weekend Fest

April 14, 2025 7:00 AM

World-renowned pioneers in psychedelics and neuroscience - including researchers, mycologists, educators, and doctors - are among the range of experts who will speak at this year's Spirituality & Beyond 5 + Oakland Psychedelic Conference this Easter weekend in Oakland. More than two dozen speakers will appear Saturday and Sunday at the Henry J. Kaiser Center for the Arts, representing the most comprehensive gathering of psychedelic expertise on...

Read more
Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak
Healthcare & PharmaceuticalCompany Update

Measles Outbreak Expands Begging for a Drug to Treat the Infection - NanoViricides Declares it is Ready to Fight the Outbreak

April 14, 2025 6:30 AM

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the "Company"), and a leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic nanomedicine technology that viruses cannot escape, announced today that it has begun evaluation of its clinical drug NV-387 for the treatment of the Measles virus."A drug for measles is at present a completely missing link in the response to measles virus outbreak,"...

Read more
NOTICE OF ANNUAL GENERAL MEETING in Senzime AB (publ)
Healthcare & PharmaceuticalShareholder Meeting

NOTICE OF ANNUAL GENERAL MEETING in Senzime AB (publ)

April 14, 2025 6:00 AM

Senzime (STO:SEZI)(OTCQX:SNZZF) - The shareholders in Senzime AB (publ) corp. reg. no 556565-5734 (the "Company") are hereby convened to an annual general meeting on Monday 19 May 2025, at 16.00 at the Company's premises on Verkstadsgatan 8, house 1, Uppsala.Notice etc.Shareholders who wish to participate in the annual general meeting must:be registered in the share register kept by Euroclear Sweden AB on Friday 9 May 2025 (the record date),...

Read more
DEA Ignored Marijuana Federal Law? MMJ's 7 Year Delay on Critical Drug Development for Suffering Patients
Healthcare & PharmaceuticalCompany Update

DEA Ignored Marijuana Federal Law? MMJ's 7 Year Delay on Critical Drug Development for Suffering Patients

April 14, 2025 5:00 AM

Senior officials at the Drug Enforcement Administration (DEA), THOMAS PREVOZNIK, MATTHEW STRAIT AND AARTHI HAIG are facing mounting scrutiny following explosive allegations that they deliberately obstructed a critical medical marijuana research application for nearly a decade, brazenly flouting federal law, presidential directives, and the agency's own stated mission to support legitimate scientific pharmaceutical development needs. The eye of...

Read more
Genflow Biosciences PLC Announces Launch of AI-Powered Partnership
Healthcare & PharmaceuticalCompany Update

Genflow Biosciences PLC Announces Launch of AI-Powered Partnership

April 14, 2025 2:00 AM

Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or "the Company"), the only publicly listed longevity company in Europe, is pleased to announce that, in addition to the recently announced launch of a new development program in ophthalmology, it has entered into a strategic partnership with Heureka Labs, Inc., a U.S.-based AI-driven discovery and analytics platform.A Master Services Agreement ("MSA") was signed by both parties on 11...

Read more
 Avant Brands Announces Results for Q1 2025
Healthcare & PharmaceuticalEarnings

Avant Brands Announces Results for Q1 2025

April 11, 2025 4:30 PM

Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BUP)("Avant" or the "Company"), a leading producer of innovative and award-winning cannabis products, today released its financial results for the first quarter ended February 28, 2025 ("Q1 2025"). Avant delivered improvements in several key financial metrics, reflecting continued progress in international markets and consistent execution across its operations. Highlights include:Gross and Net...

Read more

Join the thousands of ACCESS Newswire customers today who are getting millions of views on their news.


Check out our flexible subscription and pay as you go pricing

and packages.

Use Code NEWS10 for 10% off  of your first purchase.


Latest Blog Posts

Visit our blogs for press release tips, media engagement

Strategies, and Product Comparisons.

Executive delivering prepared remarks from an earnings call script
By Jennifer Hammers July 9, 2026
How to write earnings call prepared remarks that land — structure, length, the safe-harbor open, non-GAAP language, and building remarks around your strategy.
IR
By Brian Balbirnie July 8, 2026
A practical earnings call preparation checklist for IR teams — the two-week runway, consensus, logistics, Q&A prep, and Reg FD-clean disclosure timing.
ACCESS Newswire guide on AI investor relations — how AI assistants read company earnings disclosures
By Jennifer Hammers July 6, 2026
AI assistants read your earnings within minutes. Learn how IR teams make disclosures AI-readable — and how the LLM Citation Score measures your visibility.
What does Meltwater cost in 2026, and what are the alternatives? Meltwater resells press release dis
By Jennifer Hammers June 22, 2026
What does Meltwater cost in 2026, and what are the alternatives? See how ACCESS Newswire compares on distribution, data, and price.
A logo for accesswire next to a logo for rack
By Jennifer Hammers June 21, 2026
Compare Muck Rack vs ACCESS Newswire on pricing, features, and alternatives. See how ACCESS Newswire adds distribution, pitching, and analytics.
A blue and white logo with a check mark next to it
By Jennifer Hammers June 19, 2026
Compare Business Wire vs ACCESS Newswire on pricing and capabilities — and how ACCESS delivers comparable reach at a fraction of the cost.
Show More




Discover the news
by Industry:


Need help with your PR Strategy?
Learn more about our
professional PR Services today:

.MEDIA PRO 
Want to get noticed
by the Media but don’t
know how? 

.TOTAL PRO

Need full support to 

Optimize your PR

Efforts?